Incannex Healthcare (IXHL) Payables (2020 - 2026)
Incannex Healthcare (IXHL) posted Payables of $1.6 million for Q1 2026, up 30.67% sequentially from $1.2 million in Q4 2025, and down 34.24% YoY from $2.4 million in Q1 2025.
Incannex Healthcare (IXHL) Payables (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Payables for 7 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Payables fell 34.24% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (down 34.24% YoY) and the FY2025 annual result came in at $6.1 million, up 1052.56% from the prior year.
- Payables climbed to $1.6 million in Q1 2026 per IXHL's latest filing, from $1.2 million in the prior quarter.
- Over five years, Payables peaked at $6.1 million in Q2 2025 and troughed at $527000.0 in Q2 2024.
- A 5-year average of $1.9 million and a median of $1.6 million in 2026 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables slumped 69.85% in 2024, then jumped 1052.56% in 2025.
- Over 5 years, Payables stood at $1.1 million in 2022, then soared by 82.58% to $2.0 million in 2023, then advanced by 12.76% to $2.2 million in 2024, then tumbled by 44.3% to $1.2 million in 2025, then surged by 30.67% to $1.6 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $1.6 million, $1.2 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 986.00 Mn |
| 10 | Incannex Healthcare | 41.61 Mn | 41.61 Mn | - | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 6.07 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 527,000.00 |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Jun 30, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2021 | 755,049.00 |
| Jun 30, 2020 | 955,006.00 |